Firat, OzgurOzturk, SafakAkalin, TanerCoker, Ahmet2019-10-272019-10-2720090008-428Xhttps://hdl.handle.net/11454/43107Inflammatory myofibroblastic tumours (IMTs), previously accepted as a subtype of the group of tumours called inflammatory pseudotumours, are now recognized to comprise their own, discrete diagnosis. Since IMTs can arise from various anatomic locations,(1,2) they concern almost every subspecialty in surgical oncology. The management of these tumours can be challenging because there are no established medical treatment protocols, and tumours can be irresectable owing to their proximity to vital structures. We present the case of a patient whose IMT was removed after 2 trials of chemotherapy after 2 unsuccessful surgeries.eninfo:eu-repo/semantics/closedAccessArticle523E60E61WOS:00026819870002719503649Q2N/A